Abiopharma

News list

Director Aiken Jason W 🟡 adjusted position in 9.3K shares (2 derivative) of QXO, Inc. (QXO) Transaction Date: May 05, 2026 | Filing ID: 000007

Full text

News bot May 7, 2026, 8:02 p.m.
🔍 Aiken Jason W (Director)

Company: QXO, Inc. (QXO)

Report Date: 2026-05-05
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 21,385
- Total shares sold: 12,111
Detailed Transactions and Holdings:
- Acquired 12,111 shares of Common Stock, $0.00001 par value (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 26,634.00 | transaction_form_type: 4
- Acquired 9,274 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,274.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
- Sold 12,111 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3, F3
Footnotes:
- F1: Each restricted stock unit ("RSU") represents a contingent right to receive, upon settlement, one share of Common Stock.
- F2: The RSUs vest in full on the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director of the Issuer.
- F3: On May 12, 2025, the Reporting Person was granted RSUs that vested and settled in full on the date of the Issuer's 2026 Annual Meeting of Stockholders.